SCIENTIFIC EVENTS
Ethics for CHIM Clinical Trial Protocols Workshop
Brussels, Belgium
May 30-31, 2023
On invitation only
For further information contact the secretariat
Maintaining the Quality of Vaccines through the Use of References Standards Current Challenges and Future Opportunities
Ottawa, Canada
Hybrid meeting
June 21-22, 2023
IABS – Flanders Vaccine
The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment
Leuven, Belgium
September 19-20, 2023
9th Annual Statistics Workshop
Statistical Innovation Advancing CMC
Rockville, USA
.
.
November 7-9, 2023.
.
.
Learn more & Register
NEWS
Register now
IABS is organizing the upcoming event about Maintaning the Quality of Vaccines Through the Use of References Standards : Current Challenges and Future Opportunities. The meeting will take place on 21 and 22 of June, 2023, at the Library…
President’s Column 2022
Dear IABS Colleagues, Stakeholders, Supporters, and Collaborators,
It was an honor to assume the presidency of this prestigious organization in 2022. IABS has a celebrated history, and I am looking forward to more accomplishments…
What does IABS do that is unique ?
In this short interview, Joris Vandeputte, former President of IABS has answered the question “What does IABS do that is unique ?”
To learn more about the International Alliance for Biological…
IABS COLLABORATIONS
INNOVATIVE MEDICINES INITIATIVE (IMI) PROJECTS :
IMI is a European public-private partnership aiming to speed up the development of better and safer medicines. IMI is partly founded by the European Commission.
The IABS European Affiliate (IABS-EU) was part of consortia which have been selected by IMI to be the public partners of following consortia.
IABS-EU was selected to drive the regulatory part of those consortia.
IABS COLLABORATIONS / MANCO, A EUROPEAN COMMISSION PROJECT :
MANCO (Monclonal Antibodies against COVID-19) is one of the eighteen projects that have been successfully selected by the European Commission, which is devoted to the development of Monoclonal Antibodies agains COVID-19.
IABES-EU was selected to drive the regulatory part of the project
TESTIMONIALS
Paul Henri Lambert
Professor at University of Geneva
Founder of ADVAC
“I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…
John Petricciani
Past President
Advisor to the Board
“ Cell substrates have been a key element in the evolution of biological products since the…
Kathryn Zoon
“ As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …
Philippe Duclos
Director ADVAC
University of Geneva
“ A vibrant organization that allows dialogue beyond professional boundaries…
